These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 36275644)
1. A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer. Xu C; Li F; Liu Z; Yan C; Xiao J Front Immunol; 2022; 13():1019764. PubMed ID: 36275644 [TBL] [Abstract][Full Text] [Related]
2. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer. Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z Front Immunol; 2022; 13():951455. PubMed ID: 36189298 [TBL] [Abstract][Full Text] [Related]
3. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer. Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M Front Immunol; 2022; 13():994874. PubMed ID: 36330513 [TBL] [Abstract][Full Text] [Related]
4. Cross-Talk Between m Song W; Ren J; Xiang R; Yuan W; Fu T Front Immunol; 2022; 13():740960. PubMed ID: 35350786 [TBL] [Abstract][Full Text] [Related]
5. A Hypoxia-Related lncRNA Signature Correlates with Survival and Tumor Microenvironment in Colorectal Cancer. Zhong X; He X; Wang Y; Hu Z; Yu D; Huang H; Zhao S; Wei P; Li D J Immunol Res; 2022; 2022():9935705. PubMed ID: 35846431 [TBL] [Abstract][Full Text] [Related]
6. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients. Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M Front Immunol; 2023; 14():1279789. PubMed ID: 37928532 [TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer. Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer. Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388 [TBL] [Abstract][Full Text] [Related]
9. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
10. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer. Yu ZL; Zhu ZM Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333 [TBL] [Abstract][Full Text] [Related]
11. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
13. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis. Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; Zong Z; Zeng B; Li Y; Zhou T J Gastrointest Oncol; 2022 Aug; 13(4):1842-1863. PubMed ID: 36092325 [TBL] [Abstract][Full Text] [Related]
14. Prognostic cellular senescence-related lncRNAs patterns to predict clinical outcome and immune response in colon cancer. Cao L; Chen F; Xu L; Zeng J; Wang Y; Zhang S; Ba Y; Zhang H Front Immunol; 2024; 15():1450135. PubMed ID: 39355236 [TBL] [Abstract][Full Text] [Related]
15. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence. Yu S; Chen M; Xu L; Mao E; Sun S Front Immunol; 2023; 14():1175490. PubMed ID: 37090726 [TBL] [Abstract][Full Text] [Related]
16. [m Chen S; Dong R; Li Y; Wu H; Liu M Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):681-689. PubMed ID: 35673911 [TBL] [Abstract][Full Text] [Related]
17. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma. Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S Front Immunol; 2022; 13():918154. PubMed ID: 35880180 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer. Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319 [TBL] [Abstract][Full Text] [Related]
19. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network. Yang ZD; Kang H World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018 [TBL] [Abstract][Full Text] [Related]
20. A novel 10-gene immune-related lncRNA signature model for the prognosis of colorectal cancer. Ma B; Cao L; Li Y Math Biosci Eng; 2021 Nov; 18(6):9743-9760. PubMed ID: 34814366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]